BridgeBio Pharma Financial Overview
BridgeBio Pharma's market cap is currently $14.59B. The company's EPS TTM is $-0.95; its P/E ratio is -18.08; BridgeBio Pharma is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.
